DNA double-strand break (DSB) repair is an important mechanism underlying chemotherapy resistance in human cancers. Dicer participates in DSB repair by facilitating homologous recombination. However, whether Dicer is involved in nonhomologous end joining (NHEJ) remains unknown. Here, we addressed whether Dicer regulates NHEJ and chemosensitivity in colon cancer cells. Using our recently developed NHEJ assay, we found that DSB introduction by I-SceI cleavage leads to Dicer upregulation. Dicer knockdown increased SIRT7 binding and decreased the level of H3K18Ac (acetylated lysine 18 of histone H3) at DSB sites, thereby repressing the recruitment of NHEJ factors to DSB sites and inhibiting NHEJ. Dicer overexpression reduced SIRT7 binding and increased the level of H3K18Ac at DSB sites, promoting the recruitment of NHEJ factors to DSBs and moderately enhancing NHEJ. Dicer knockdown and overexpression increased and decreased, respectively, the chemosensitivity of colon cancer cells. Dicer protein expression in colon cancer tissues of patients was directly correlated with chemoresistance. Our findings revealed a function of Dicer in NHEJ-mediated DSB repair and the association of Dicer expression with chemoresistance in colon cancer patients.
Introduction
Dicer is a key component of the RNA interference pathway and is essential for the biogenesis of micro-RNAs (miRNAs), small interfering RNAs (siRNAs), and DNA double-strand break (DSB)-induced small RNAs (diRNAs) or DNA damage response RNAs (DDRNAs) (1) (2) (3) (4) (5) . Previously, we and other investigators reported that Dicer depletion leads to DNA damage (6) (7) (8) (9) (10) . Recent years have witnessed significant advances in understanding the role of Dicer and the underlying molecular mechanism in the DNA damage response (DDR). Dicer is required for the biogenesis of diRNAs/DDRNAs, which is critical for DDR foci formation. Decreased Dicer expression impedes homologous recombination (HR)-mediated DNA repair as a result of diRNA deficiency (4, 11) . DiRNAs/DDRNAs recruit the chromatin-modifying enzymes MMSET and Tip60 to DSB sites, where they create an open, flexible chromatin configuration (12) and facilitate the recruitment of DDR mediators MDC1 and 53BP1 (5) . In Dicerdeficient cells, deregulation of the DDR pathway by miRNA down-regulation may block DNA repair (7, 10, 13) . Dicer may contribute to genomic stability by promoting transcription termination at sites of replication stress, as shown in the fission yeast Schizosaccharomyces pombe, where Dicer loss leads to transcription termination defects and genome instability (14) .
Recently, we found that the Dicer protein interacts with SIRT7, an NAD (+)-dependent acetylated lysine 18 of histone H3 (H3K18Ac) deacetylase, and maintains a pool of SIRT7 molecules in the cytoplasm. DNA-damaging agents induce Dicer expression, which results in increased trapping of SIRT7 in the cytoplasm and inhibits H3K18Ac deacetylation. Dicer knockdown leads to an increase of chromatin-associated SIRT7, thus preventing the DNA damage-induced increase in H3K18Ac (15) . Chromatin architecture plays pivotal roles in DDR, and aberrant chromatin structure promotes genome instability (16) (17) (18) . DNA damage induces extensive chromatin relaxation, which facilitates the access of DNA repair machinery to DNA breaks and is essential for DNA damage repair (16, 17) . For example, histone acetylation by CBP/p300 at DSB sites facilitates the recruitment of non-homologous end joining (NHEJ) factors (19) , whereas CBP or p300 ablation suppresses the recruitment of KU70 and KU80, two core components of the NHEJ machinery, to DSB sites (19, 20) . Based on these observations, we speculated that downregulation of Dicer expression would repress NHEJ efficiency. Given that repair of DSB by NHEJ and HR is an important mechanism underlying chemotherapy resistance of malignant tumors, including colon cancer, identification of new players in this process should promote the development of novel approaches to improve the response to chemotherapy for colon cancer patients.
Materials and methods

Plasmids
Herein, we used previously described Dicer knockdown (shDicer1 and shDicer2) and control shRNA (shCon) plasmids, the pFlag-SIRT7 (WT) plasmid (15) and the pSceI-Hygro-EGFP plasmid (12) . The pCBASceI and pDESTmycDICER (termed pDicer herein) plasmids were obtained from Addgene (Cambridge, MA, USA) (21) (22) (23) .
The pLVX-Tight-HA-I-SceI plasmid was constructed by inserting a DNA fragment containing an HA-tagged codon-optimized I-SceI-coding sequence into the pLVX-Tight-puro plasmid (Clontech, Mountain View, CA, USA).
Cell culture and generation of stable cell lines
HEK293T and RKO cells (ATCC, Manassas, VA, USA) were grown in Dulbecco's modified Eagle medium (Hyclone, Logan, UT, USA), and HCT116 cells (ATCC) were grown in McCoy's 5A medium (Life Technologies, Grand Island, NY), supplemented with 10% fetal bovine serum, with incubation at 37°C in a humidified incubator with a 5% CO 2 atmosphere. Cell lines were authenticated by genetic profiling using polymorphic short tandem repeat (STR) loci. Mycoplasma contamination is routinely tested in our laboratory. Stable Dicer-knockdown and Dicer-overexpressing HCT116 cells were described previously (15) .
HEK293T-I-SceI-Hygro-EGFP cells were generated by transfecting the pSceI-Hygro-EGFP plasmid into HEK293T cells using Lipofectamine 2000 (Life Technologies, 11668019) according to the manufacturer's instructions. As a result, two clones resistant to hygromycin B (50 μg/ml) were obtained (HEK293T-Hygro-EGFP #1 and #2). The association of SIRT7 with the I-SceI region was validated by the ChIP assay.
HCT116-I-SceI-Hygro-EGFP cells expressing HA-I-SceI under the control of a tetracycline-inducible promoter were generated by transfecting HCT116 cells with the pTet-On-Advanced vector (Clontech). Cells were selected with 1000 μg/ml G418, and a G418-resistant clone was transfected with the pLVX-Tight-HA-I-SceI plasmid to obtain a clone resistant to puromycin (2.5 μg/ml) and G418. The double-resistant clone was further transfected with the pSceI-Hygro-EGFP plasmid and selected using 50 μg/ ml hygromycin B. The drug-resistant clone was tested for the association of SIRT7 with the I-SceI region using the ChIP assay.
Transfection with siRNA
Cells were transfected with Dicer and control siRNAs, which have been described previously (15) (50 nM) using Lipofectamine 2000.
Comet assay
The Comet assay was performed as described previously (6) . Comet images were visualized using a fluorescence microscope (Leica DMI3000 B).
NHEJ assay in HCT116 and HEK293T cells
The NHEJ assay was performed as described previously with modifications (24) . Briefly, the HCT116-I-SceI-Hygro-EGFP cells were treated with doxycycline (Dox) (500 μg/ml) to induce HA-I-SceI expression, which in turn induced DSB formation. To determine the effect of Dicer knockdown on NHEJ, the HCT116-I-SceI-Hygro-EGFP cells were transfected with Dicer or control siRNAs, and Dox was added 12 h after transfection. To determine the effect of Dicer overexpression on NHEJ, the HCT116-I-SceI-Hygro-EGFP cells were transfected with the pDicer, or pcDNA3.1 plasmid, and Dox was added 12 h after transfection. The NHEJ assay in HEK293T cells was performed by transfecting HEK293T-Hygro-EGFP clones with the pCBASceI plasmid. To determine the effect of Dicer knockdown on NHEJ, HEK293T-I-SceI-Hygro-EGFP cells were co-transfected with the pCBASceI or pcDNA3.1 plasmid and Dicer or control siRNAs. To determine the effect of Dicer overexpression on NHEJ, HEK293T-I-SceI-Hygro-EGFP cells were co-transfected with the pCBASceI or control (pcDNA3.1) and the pDicer, or control (pcDNA3.1) plasmids. NHEJ was assessed by fluorescence-activated cell sorting (FACS) and quantitative PCR. NHEJ efficiency was determined as the proportion of joined DNA and EGFP-positive cells at the indicated time points. For FACS analysis, cells were trypsinized, washed with PBS, and applied to a FACSCalibur system (Becton Dickinson, Franklin Lakes, NJ, USA).
To quantify the uncut and joined DNA, 20 ng of genomic DNA was subjected to quantitative PCR using SYBR premix Ex Taq (TaKaRa, Dalian, China, RR820A) and an ABI 7300 Sequence Detection System (Life Technologies). The RPS20 promoter was used as an internal control. The primers were as follows: joined DNA, 5′-GCACCAAAATCAACGGGACT-3′ and 5′-GCTGAACTTGTGGCCGTTTA-3′; uncut DNA, 5′-GCACCAAAATCAACGGG ACT-3′ and 5′-AAAGCACGAGATTCTTCGCC-3′; RPS20 promoter, 5′-AAGTT CTTTCTTTTTGAGGAAGACG-3′ and 5′-GAACAGCGGTGAGTCAGGA-3′. The amount of joined DNAs and uncut DNAs was normalized to the amount of RPS20 promoter DNA. The relative proportion of uncut DNAs was expressed as the ratio to the amount of uncut DNA at the start of pCBASceI transfection or induction, which was defined as having a value of 1. The relative proportion of joined DNAs was expressed as the ratio to the amount of joined DNA 48 h after pCBASceI transfection, which was defined as having a value of 1. 
Abbreviations
ChIP
ChIP assay
The ChIP assay was performed using the Chromatin Immunoprecipitation Assay Kit (Millipore Danvers, MA, USA) according to the manufacturer's instructions. The antibodies used for ChIP were: anti-SIRT7 (5360S), anti-H3K18Ac (9675S) and anti-KU80 (2753) (Cell Signaling Technology, Danvers, MA, USA) and anti-53BP1 (GTX30658) and anti-KU70 (GTX101820) (GeneTex, Irvine, CA, USA). The precipitated DNA was quantified by quantitative PCR using the following primers: 5′-CCAAGTCTCCACCCCATTGA-3′ and 5′-GCGGATCTGACGGTTCACTA-3′. The proportion of DNAs cross-linked to proteins was calculated based on the quantity of DNA in the input control samples at each time point.
The relative enrichment of a protein at DSB sites was expressed as the amount of immunoprecipitated DNA divided by the amount of input DNA, and plotted as ratios against the values for the corresponding controls, which were defined as 1.
Western blotting
Western blotting was performed as described previously (15) . Primary antibodies used in this study were: anti-Dicer (Abcam, ab14601), anti-GAPDH (Boster, Wuhan, China, BM1623) and anti-HA (GeneTex, Irvine, CA, USA, GTX115044).
Animal studies
To evaluate the effect of Dicer overexpression or knockdown on cancer cell chemosensitivity, stable Dicer-deficient and Dicer-overexpressing HCT116 cells were subcutaneously injected into 6-8-week-old BALB/c female athymic nude mice (Vital River Experimental Animal Center, Beijing, China) to generate tumor xenografts. Tumors were measured using a caliper, and tumor volume was calculated as: V = L × W 2 × 0.5236 (L, long axis; W, short axis). When tumor masses became visible (~100 mm 3 ), mice were intraperitoneally (i.p.) injected with 5-fluorouracil (5-FU, 50 mg/kg) or doxorubicin (5 mg/kg) in 0.9% NaCl every 2 days for 2 weeks. The mice were then euthanized, and tumors were harvested and weighed. All animals were maintained and treated in accordance with the guidelines of the Institutional Animal Care and Use Committee of Wenzhou Medical University.
Cell proliferation assay
The cell proliferation assay was performed as described previously (15) .
Human colon cancer specimens and immunohistochemistry
Eighty-eight colon cancer samples were collected from patients who underwent surgery or biopsy, and then chemotherapy in the First None of the patients received chemotherapy before surgery or biopsy. Samples were fixed in formalin and embedded in paraffin. Then, 5-µm-thick sections were prepared, mounted on charged slides, and incubated at 60°C overnight. Tissue slices were dewaxed in xylene, dehydrated in ethanol and subjected to antigen retrieval in 1 mM EDTA buffer (pH 8.0) for 22 min in a microwave. Sections were cooled, washed three times with PBS, and incubated with anti-Dicer antibody (1:50) at 25°C for 3 h. After washing with PBS, sections were incubated with biotinylated secondary antibody and HRP-streptavidin complex for 15 min (Maixin Bio, Fuzhou, China, KIT9921), and the color reaction was developed with 3,3′-diaminobenzidine (DAB; Maixin Bio, ABD0030). Then, sections were counterstained with hematoxylin, washed, dehydrated in ethanol, cleared in xylene and mounted on coverslips. Dicer-overexpressing and Dicer-knockdown cells were used as positive and negative controls, respectively, in each of the staining experiments. Immunoreactivity was scored as: 0, no staining; 1, weak staining; 2-4, intermediate staining and 5, strong staining. The score for each section was determined independently by three pathologists, and the final score was calculated as the average of three independent scores.
TCGA data sets analysis and statistical analysis
The Cancer Genome Atlas (TCGA) expression and clinical data associated with the tumors were obtained from the TCGA Data Portal (http:// cancergenome.nih.gov/). The relationship between Dicer expression levels and survival was explored in the TCGA data sets by selecting from each cohort the cases with high and low expression and separating them into two groups using a data-driven approach (26) . Kaplan-Meier plots were constructed, and a log-rank test was used to determine the association of patient survival with gene expression. The univariate hazard ratio was calculated with 95% confidence intervals (95% CIs) using the Cox proportional hazards model, and significance was assessed using Wald's test.
Each experiment was independently conducted at least three times. Continuous variables were expressed as the mean ± SEM, and categorical values were expressed as absolute and relative frequencies. Differences in continuous and categorical variables were analyzed using Student's t-test or Mann-Whitney U test and the chi-squared test, respectively. The correlation between two variables was assessed by Spearman correlation analysis. Statistical analyses were performed using SPSS 22.0 (SPSS, Chicago, IL, USA). All statistical tests were two-sided, and P < 0.05 was considered statistically significant. 
Results
DSB introduction by I-SceI cleavage leads to Dicer upregulation
To assess the association of DNA repair with Dicer expression, we employed our recently developed NHEJ assay (24) . Briefly, the pSceI-Hygro-EGFP plasmid containing two I-SceI endonuclease recognition sites in the reverse orientation was integrated into chromosomal DNA of HEK293T cells and used as a substrate for DSB formation and NHEJ repair. Given that no I-SceI sites are present in the human genome, transiently expressed I-SceI specifically cleaves the substrate at I-SceI sites to generate DSBs. NHEJ of the two broken DNA strands resulted in the deletion of the hygromycin B phosphotransferase open reading frame and enabled the expression of enhanced green fluorescent protein (EGFP) (Supplemtary Figure 1A , available at Carcinogenesis Online). We identified two individual HEK293T clones stably carrying the I-SceI-Hygro-EGFP sequence in the genome, where SIRT7 was bound to the I-SceI region. The kinetics of DSB generation were determined by quantifying the proportion of uncut DNA (Supplementary Figure 1B , available at Carcinogenesis Online), and NHEJ dynamics were assessed by quantifying the proportion of joined DNA and monitoring EGFP production (Supplementary Figure 1C and D, available at Carcinogenesis Online). Consistent with the report that DNA-damaging treatments induced Dicer expression (15) , we demonstrated that DSB introduction into the HEK293T genome by I-SceI cleavage led to Dicer upregulation, which gradually returned to normal 72-h post-transfection, when the two broken DNA ends were joined ( Figure 1A) . We also generated an HCT116-I-SceI-Hygro-EGFP clone stably carrying I-SceI-Hygro-EGFP DNA in the genome and expressing HA-I-SceI under control of a tetracycline-inducible promoter. The induction of DSBs in HCT116-I-SceI-Hygro-EGFP cells by doxycycline (Dox) also led to Dicer upregulation ( Figure 1B) .
DSB-induced Dicer upregulation decreases the level of SIRT7 and increases the level of H3K18Ac at DSB sites
DNA damage induces Dicer expression, which in turn promotes SIRT7 redistribution from chromatin to the cytoplasm and prevents H3K18Ac deacetylation (15) . Consistent with this observation, chromatin immunoprecipitation (ChIP) analysis revealed that SIRT7 association with the I-SceI region was decreased at 24 h post-transfection, when DSBs were induced, and returned to normal at 72 h, when the two broken DNA ends were joined ( Figure 1C ). Consistently, the H3K18Ac level at the I-SceI region was increased at 24 h and returned to normal at 72 h post-transfection ( Figure 1C ). To confirm that the increase in H3K18Ac at DSB sites resulted from a reduction of SIRT7 binding at the I-SceI region induced by Dicer upregulation, we examined the effects of Dicer knockdown and SIRT7 overexpression on H3K18Ac levels at DSB sites. As expected, Dicer knockdown and SIRT7 overexpression prevented the reduction of SIRT7 binding and the increase of H3K18Ac levels at the I-SceI region upon DSB induction (Figure 1D and E; Supplementary Figure 2B and D, available at Carcinogenesis Online). However, DSB induction was not affected, as evidenced by the unchanged proportion of uncut DNA in Dicer-deficient or SIRT7-overexpressing cells (Supplementary Figure 2A and C, available at Carcinogenesis Online). Although Dicer knockdown led to an increase in SIRT7 binding at the I-SceI region even without DSB induction, it did not obviously reduce the level of H3K18Ac at this region when DSB was absent ( Figure 1D ). This observation is consistent with our previous report that although Dicer knockdown led to an obvious decrease of H3K18Ac in response to DNA-damaging agents by preventing SIRT7 redistribution from chromatin to the cytoplasm, it did not affect the level of H3K18Ac under normal conditions (15) . Consistent with a previous report that SIRT7 knockdown did not significantly increase the level of H3K18Ac under normal conditions (27) , we found that SIRT7 overexpression did not markedly increase H3K18Ac levels in the absence of DSB induction at the I-SceI region ( Figure 1E ). 
Dicer knockdown suppresses the recruitment of NHEJ factors to the DSB sites and impedes NHEJ
Histone acetylation by CBP/p300 at DSB sites facilitates the recruitment of NHEJ factors to DSBs (19) , whereas CBP or p300 deficiency inhibits this process (19, 20) . We then investigated the effect of Dicer knockdown on the recruitment of 53BP1, KU70, and KU80, which are the three core components of the NHEJ machinery (28) , to DSB sites. In Dicer-knockdown cells, the recruitment of 53BP1, KU70 and KU80 to DSBs decreased compared to that in control cells (Figure 2A) . Accordingly, Dicer knockdown reduced the proportion of both EGFP-positive cells and joined DNA (Figure 2B and C) . Similar results were obtained in HCT116-I-SceI-Hygro-EGFP cells (Figure 2D-F) .
Dicer knockdown increases chemosensitivity of colon cancer cells
The observations that Dicer knockdown repressed DSB repair mediated by HR (4) and NHEJ led us to hypothesize that Dicer downregulation might increase the sensitivity of cancer cells to DNA-damaging agents. Cell proliferation and Comet assays revealed that Dicer knockdown increased the chemosensitivity of HCT116 and RKO cells to 5-fluorouracil (5-FU) and doxorubicin (DOXO) ( Figure 3A -C and Supplementary Figure 3A and B, available at Carcinogenesis Online). To evaluate the effects of Dicer knockdown on the sensitivity of colon cancer cells to DNA-damaging agents in vivo, we established xenografts from control and Dicer-deficient HCT116 cells in athymic nude mice. Consistent with a previous report that both Dicer knockdown and Dicer overexpression in HCT116 cells inhibited cell proliferation (15) , Dicer knockdown suppressed the tumor xenograft growth of HCT116 cells ( Figure 3D , E, H and I; Supplementary Figure 3C 
Dicer overexpression facilitates the recruitment of NHEJ factors to DSB sites and promotes NHEJ
Consistent with a previous report that Dicer overexpression induced SIRT7 relocation from chromatin to the cytoplasm (15), we found that in Dicer-overexpressing cells, SIRT7 binding was reduced and H3K18Ac levels were increased at DSBs (Figure 4A and B), thereby promoting the recruitment of 53BP1, KU70, and KU80 to DSB sites ( Figure 4C) . Moreover, Dicer overexpression in HCT116 cells increased NHEJ efficiency by ~1.5-fold ( Figure 4D ).
Dicer overexpression reduces chemosensitivity of colon cancer cells
We then examined the effect of Dicer overexpression on the chemosensitivity of colon cancer cells. Cell proliferation and Comet assays revealed that Dicer overexpression increased the resistance of HCT116 and RKO cells to 5-FU and DOXO treatment ( Figure 5A -C and Supplementary Figure 4A -C, available at Carcinogenesis Online). To evaluate the effects of Dicer overexpression on cancer chemosensitivity in vivo, we established xenografts from control or Dicer-overexpressing HCT116 cells in athymic nude mice. Consistent with a previous report that Dicer overexpression inhibited cell proliferation (15) , the growth of Dicer-overexpressing xenografts was slower than that of the control ( Figure 5D-F) . Interestingly, the sensitivity to 5-FU treatment was reduced in Dicer-overexpressing xenografts compared to that in the control (Figure 5D-G) .
Increased Dicer expression in colon cancer tissues reduces response to chemotherapy
We then examined Dicer expression in 88 colon cancer tissues, including 5 from patients with complete response (CR), 20 from patients with partial response (PR), 33 from patients with stable disease (SD), and 30 from patients with progressive disease (PD). Our data revealed that Dicer expression in chemorefractory colon cancer tissues was higher than that in chemosensitive tissues (Figure 6A-C and Supplementary Table 2, available at Carcinogenesis Online) and inversely correlated with tumor regression, measured by changes in the longest diameter after 2 months of chemotherapy ( Figure 6D ), indicating that the upregulation of Dicer in colon cancer cells reduces their sensitivity to chemotherapy.
Discussion
In summary, we showed here that the introduction of DSBs by I-SceI cleavage caused transient Dicer upregulation, which in turn reduced the association of SIRT7 with DSB sites and increased the level of H3K18Ac. Dicer knockdown and overexpression prevented and promoted, respectively, SIRT7 reduction and H3K18Ac increase at DSB sites. Consistent with a previous report regarding the effects of histone acetylation on NHEJ (19) , our data indicate that Dicer deficiency inhibited the recruitment of NHEJ factors to DSB sites and impaired NHEJ, whereas Dicer overexpression caused the opposite effect. Taken together, these data indicate that transient sequestration of SIRT7 in the cytoplasm owing to Dicer upregulation increases H3K18 acetylation at sites of damaged DNA and facilitates NHEJ-mediated DNA repair, suggesting a function of Dicer in DDR.
Previously, we reported that DNA-damaging agents promoted Dicer expression (15) . Here, we showed that Dicer knockdown impaired NHEJ and sensitized colon cancer cells to DNA-damaging agents, whereas Dicer overexpression promoted NHEJ and decreased the sensitivity of colon cancer cells to chemotherapy, suggesting that Dicer upregulation induced by DNA-damaging agents may facilitate DNA repair. Consistently, we found that Dicer expression in colon cancer tissues was correlated with chemoresistance. Our findings are in agreement with previous reports that Dicer-deficient cells are more sensitive to UV and gamma irradiation (29, 30) . However, in contrast to our findings, Liu and colleagues reported that Dicer knockdown promoted NHEJ and increased cell resistance to camptothecin by blocking the G1/S transition (31). Kawahara and colleagues reported that low Dicer expression was associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma (32) . The discrepancy in these findings might be explained by the pleiotropic effects of Dicer on cell proliferation and cell cycle progression. Kumar et al. reported that Dicer knockdown promoted tumor cell proliferation (33) , and other groups indicated that Dicer knockdown suppressed the growth of different cancer cell lines (34, 35) . Chemotherapeutic agents used in cancer treatment induce DNA breaks in rapidly dividing cancer cells, and DNA repair efficiency and chemosensitivity are affected by the cell proliferation rate and cell cycle distribution. We found that Dicer overexpression inhibited the proliferation of HCT116 and RKO colon cancer cells, suggesting that Dicer overexpression in colon cancer cells may induce chemoresistance by inhibiting cell proliferation. Paradoxically, Dicer knockdown also repressed the proliferation of HCT116 and RKO cells but sensitized colon cancer cells to chemotherapeutic agents. Moreover, both Dicer overexpression and Dicer knockdown in HCT116 and RKO cells did not affect the cell cycle distribution (data not shown). These results indicate that Dicer plays a role in DNA repair and chemosensitivity independent of its effects on cell proliferation and cell cycle progression.
Although controversial, Dicer mRNA and protein levels have been frequently found to be decreased in different types of human cancer tissues (36), and lower Dicer expression level was found to be correlated with a negative outcome in lung, breast, skin, endometrial and ovarian cancers (36) . A similar discrepancy was revealed by our analysis of gene expression data in 7857 tumor tissues downloaded from the TCGA database. We found that low Dicer expression was correlated with negative outcomes in uterine corpus endometrial carcinoma, pancreatic adenocarcinoma, acute myeloid leukemia, brain lower grade glioma, and kidney renal clear cell carcinoma, but with positive outcomes in bladder urothelial carcinoma, mesothelioma, cholangiocarcinoma, thyroid carcinoma and stomach adenocarcinoma. In other cancers, Dicer expression was not associated with overall survival (Supplementary Table 3 , available at Carcinogenesis Online). These seemingly contradictory data might be explained by the following model. On the one hand, Dicer functions as a haploinsufficient tumor suppressor (37) and a decrease in its expression may promote tumor progression and lower survival rates; on the other hand, Dicer downregulation may sensitize cancer cells to chemotherapy and therefore increase the survival of cancer patients.
According to the 'access repair restore' model, chromatin architecture plays pivotal roles in DDR. Upon DNA damage, chromatin remodeling factors and histone-modifying enzymes act synergistically to create open chromatin structures, thus allowing the DNA-repair machinery to access damage sites; chromatin modifiers then remodel chromatin for damage processing and repair. Finally, local chromatin organization is restored once the repair is completed (17, 18) . Our data indicate that SIRT7 is released from chromatin upon DSB induction and is recruited back during DNA end-joining. It has been demonstrated that SIRT7 is mobilized to DSBs to promote chromatin condensation and DSB repair, whereas SIRT7 depletion impairs chromatin compaction during DDR and increases cell sensitivity to genotoxic stresses (38, 39) . Taken together, these data suggest the following mode of action for Dicer and SIRT7 in DDR: immediately upon DSB formation, transient Dicer upregulation leads to SIRT7 release from DSBs or prevents premature recruitment of SIRT7 to DSBs to facilitate chromatin opening; then, at DNA end joining, SIRT7 is recruited to chromatin to restore its local structure. This model may explain why Dicer overexpression only moderately rather than dramatically increased NHEJ efficiency and why SIRT7 overexpression marginally decreased rather than increased NHEJ (40) .
Taken together, our data indicate that in addition to a role in HR, Dicer is also essential for NHEJ-mediated DSB repair. Moreover, Dicer plays a role in the resistance of colon cancer cells to chemotherapy, suggesting that Dicer could be a new candidate target for future therapeutic approaches.
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Supplementary data are available at Carcinogenesis online.
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